Our customers' Feedback
Search:
Perform search
Categories list

Generic Onglyza

News
Onglyza
Onglyza photo

Generic Onglyza (Saxagliptin)

Diabetes

PackagePricePer PillSavingsOrder
5mg × 28 pills$124.95$4.46Add to cart
5mg × 56 pills$224.95$4.02$24.95Add to cart
5mg × 84 pills$309.95$3.69$64.90Add to cart

Most popular quantity.
Prandin
$ 0.83
Generic Prandin
(Repaglinide 0.5/1/2mg)
Precose
$ 0.96
Generic Precose
(Acarbose 25/50mg)
Starlix
$ 0.83
Generic Starlix
(Nateglinide 60/120mg)
Actoplus Met
$ 1.30
Generic Actoplus Met
(Metformin And Pioglitazone 500mg)
Actos
$ 1.22
Generic Actos
(Pioglitazone Hydrochloride 15/30mg)
Amaryl
$ 1.00
Generic Amaryl
(Glimepiride 1/2/4mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • New Study Reports on the Dangers of Combining Onglyza with Other Diabetes Drugs - Legal Examiner

    New Study Reports on the Dangers of Combining Onglyza with Other Diabetes DrugsLegal ExaminerIn early 2014, the FDA warned about study results that suggested the type 2 diabetes drug Onglyza could be linked to the risk of heart failure.

  • Onglyza does not increase risk for hospitalized heart failure - Healio

    Onglyza does not increase risk for hospitalized heart failureHealioAccording to the researchers, the SAVOR-TIMI 53 trial showed an increased risk for hospitalized HF related to Onglyza (saxagliptin, AstraZeneca).

  • Plaintiffs Ask Calif. Court to Designate Onglyza Action 'Complex' For Discovery Purposes - HarrisMartin Publishing

    Plaintiffs Ask Calif.

  • AstraZeneca: Kontingente für Onglyza - APOTHEKE ADHOC

    APOTHEKE ADHOCAstraZeneca: Kontingente für OnglyzaAPOTHEKE ADHOCBerlin - Seit einiger Zeit beklagen Apotheker immer wieder Lieferengpässe beim Antidiabetikum Onglyza (Saxaglipin) von AstraZeneca.

  • FDA warns on heart failure risk associated with Onglyza, Nesina - BioPharma Dive

    FDA warns on heart failure risk associated with Onglyza, NesinaBioPharma DiveThe FDA is adding new warnings to the labels for AstraZeneca's Onglyza (saxagliptin) and Takeda's Nesina (alogliptin) after an internal safety review found an increased risk of heart failure with the two diabetes drugs.

    Copyright © cheapgenerics24.com